FDMT News
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2026-08-13 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 2.02. |
| 2026-07-20 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 8.01. |
| 2026-06-29 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 1.01,2.03. |
| 2026-06-22 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2026-05-07 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-03-30 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 5.02. |
| 2026-03-18 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-01-26 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 3.02,9.01. |
| 2026-01-07 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 2.02,5.02. |
| 2025-12-10 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 8.01. |
| 2025-11-17 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 5.02. |
| 2025-11-10 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-11-07 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2025-11-06 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 2.02,8.01. |
| 2025-10-31 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 1.01. |
| 2025-10-02 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 5.02,5.03,9.01. |
| 2025-08-11 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-07-02 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 5.02,8.01. |
| 2025-06-20 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2025-05-08 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-02-28 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-02-10 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 8.01. |
| 2025-01-10 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 2.02,8.01,9.01. |
| 2024-12-11 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 3.02,9.01. |
| 2024-11-13 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-09-18 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 8.01. |
| 2024-08-08 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-07-23 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 7.01. |
| 2024-07-17 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 8.01. |
| 2024-06-07 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 1.01,9.01. |
| 2024-05-24 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2024-05-09 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-02-29 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-02-09 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2024-01-04 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 5.02. |
| 2023-11-22 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 5.03,9.01. |
| 2023-11-09 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2023-09-13 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 5.02. |
| 2023-08-09 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2023-07-11 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 1.01. |
| 2023-05-25 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2023-05-11 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2023-05-09 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2023-03-15 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2023-02-03 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 8.01. |
| 2023-01-26 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 8.01. |
| 2022-11-09 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2022-09-27 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 5.02. |
| 2022-08-11 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2022-06-21 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 5.03,9.01. |
| 2022-05-27 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2022-05-12 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2022-03-28 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2022-02-22 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 5.02. |
| 2022-01-11 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2021-11-10 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2021-10-26 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 8.01. |
| 2021-10-13 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 8.01. |
| 2021-09-24 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 5.02,9.01. |
| 2021-08-12 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2021-06-25 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 1.02,8.01,9.01. |
| 2021-05-20 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2021-05-13 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2021-03-25 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2020-12-15 | Current report | SEC filing | 4D Molecular Therapeutics, Inc. filed Form 8-K | 4D Molecular Therapeutics, Inc. filed Form 8-K covering items 5.03,8.01,9.01. |